表紙
市場調査レポート

心筋虚血:世界の治験レビュー

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 242608
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
心筋虚血:世界の治験レビュー Myocardial Ischemia Global Clinical Trials Review, H2, 2014
出版日: 2014年09月21日 ページ情報: 英文 71 Pages
概要

冠状動脈が部分的あるいは完全に遮断されて心筋への血流が減少すると、心筋虚血が起こります。 血流量が減少すると、心臓への酸素供給が減るため、心筋虚血によって心筋はダメージを受け、血液を効率的に送り出す能力が低下します。冠状動脈が突然遮断されると心臓発作につながる場合もあります。また、心筋虚血によって、重篤な不整脈が起きる場合もあります。 処置は、心筋への血流を改善することを第一とし、遮断された動脈を開く薬物療法か、冠状動脈バイパス手術を行います。 心臓の健康にとって好ましいライフスタイルを選択することは、心筋虚血の治療と予防の上で重要です。

当レポートでは、心筋虚血に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 心筋虚血とは
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 上位5ヶ国における治験件数; 中東/アフリカ地域
    • 上位5ヶ国における治験件数; 中南米

G7諸国における治験件数: 心筋虚血 治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数: 心筋虚血 治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 心筋虚血 治療薬

有望な薬剤

  • 最新治験ニュース: 心筋虚血

治験のプロファイル

  • 代表的な企業の治験の概要
    • Pfizer Inc.
    • Gilead Sciences, Inc.
    • Abbott Laboratories
    • Sanofi
    • Merck & Co., Inc.
    • Novartis AG
    • Medicure Inc.
    • Cytori Therapeutics, Inc.
    • Baxter International Inc.
    • Actavis plc
  • 代表的な研究機関病院の治験の概要
    • National Heart, Lung, and Blood Institute
    • U.S. Department of Veterans Affairs
    • Medical University of Vienna
    • Imperial College London
    • Seoul National University Hospital
    • Hartford Hospital
    • Erasmus MC
    • Ottawa Hospital Research Institute
    • Flinders Medical Centre
    • Assistance Publique - Hopitaux de Paris

5大治験プロファイル

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myocardial Ischemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myocardial Ischemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Myocardial Ischemia
    • Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Medicure Inc.
      • Clinical Trial Overview of Medicure Inc.
      • Cytori Therapeutics, Inc.
      • Clinical Trial Overview of Cytori Therapeutics, Inc.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Hartford Hospital
      • Clinical Trial Overview of Hartford Hospital
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Flinders Medical Centre
      • Clinical Trial Overview of Flinders Medical Centre
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flinders Medical Centre, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top